Showing results (451-460 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|February 23, 2018
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma modelUrska Kamensek, Maja Cemazar, Ursa Lampreht Tratar, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2017
Human c-SRC kinase (CSK) overexpression makes T cells dummyElse Marit Inderberg, Nadia Mensali, Morten P Oksvold, et al.Cancer Immunology, Immunotherapy : CII|January 23, 2023
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50E Pons-Tostivint, P Hulo, V Guardiolle, et al.Cancer Immunology, Immunotherapy : CII|January 25, 2023
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 studyAlessandro Rizzo, Veronica Mollica, Valentina Tateo, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2002
Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responsesM M Whitmore, S Li, L Falo, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2002
Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10)D A Arenberg, E S White, M D Burdick, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2002
Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transferT Schirrmann, G PecherCancer Immunology, Immunotherapy : CII|January 5, 2002
Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapyL Sanz, P Kristensen, S J Russell, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2002
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytesE S Bergmann-Leitner, S I AbramsCancer Immunology, Immunotherapy : CII|January 25, 2002
Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccinesYum L Yip, Robyn L WardPageof 650